Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial

This publication has 65 references indexed in Scilit:

• Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
  JAMA, 2004
• Transdermal 17-β-Estradiol and Risk of Developing Type 2 Diabetes in a Population of Healthy, Nonobese Postmenopausal Women
  Diabetes Care, 2004
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• The effects of sequential combined oral 17??-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study
  Menopause, 2001
• Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Increased Serum Levels of Growth Hormone and Insulin-Like Growth Factor-I Associated with Simultaneous Decrease of Circulating Insulin in Postmenopausal Women Receiving Hormone Replacement Therapy
  Menopause, 1999
• Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up
  BJOG: An International Journal of Obstetrics and Gynaecology, 1997
• Compendium of Physical Activities: classification of energy costs of human physical activities
  Medicine & Science in Sports & Exercise, 1993
• Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trondelag diabetes study.
  Journal of Epidemiology and Community Health, 1992
• Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women
  Journal of Clinical Epidemiology, 1991